ABOUT

About YMC ChromaCon — The Team Behind Continuous Chromatography

Inventors of MCSGP, CaptureSMB®, and N-Rich® — the twin-column processes now validated at GMP commercial scale at Bachem and Bristol Myers Squibb. Zurich-based, worldwide via YMC.

Speak to an Expert
Visit Our Application Lab
Speak to an Expert
Visit Our Application Lab

Our Story

ChromaCon began in 2006 with a question: why should purification be the bottleneck in biopharmaceutical manufacturing?

Our founders, working from deep expertise in separation science, saw that batch chromatography—despite being the industry standard—left significant room for improvement.

Their answer was continuous chromatography. Combining the advantages of counter-current movement and automated cyclic operation, this approach dramatically improved process economics while reducing waste.

What started as a research group grew into a company with a unique portfolio of process patents. By 2019 ChromaCon became part of the YMC Group of companies.

Our Mission

We exist to help biopharmaceutical teams purify smarter.

That means providing continuous chromatography solutions that genuinely outperform conventional methods—not marginally, but substantially. Our continuous manufacturing approach delivers 30-50% reductions in both capital and operating costs compared to traditional batch processing, higher yields, better resin utilization, reduced IPCs and eluent consumption. It provides more product from the same input material – or the same product amount with significantly less input.

Whether you’re working with monoclonal antibodies, oligonucleotides, peptides, or emerging modalities like mRNA and viral vectors, our goal is the same: give you the tools and expertise to move from development to manufacturing with confidence, and ultimately get effective treatments to the patients who need them.

Our Technology

CaptureSMB® optimizes capture steps by running two columns in a synchronized sequence, maximizing resin loading capacity while minimizing buffer consumption. The result: significantly lower cost of goods for high-value molecules.

MCSGP together with AutoPeak® dynamic process control, tackles complex polishing separations where conventional methods struggle. It achieves high purity and yield simultaneously—particularly valuable for closely related impurities that traditional chromatography can’t cleanly resolve.

These processes run on our Contichrom® platform. The Contichrom CUBE—a twin-column FPLC development system—lets teams evaluate multiple continuous processes and select the best approach for any given separation challenge. Processes developed on the CUBE scale directly to our GMP-capable manufacturing system lines, the Contichrom PILOT & TWIN. Our ChromIQ® software provides intuitive control and comprehensive data management throughout.

Learn About Contichrom® Technologies

How We Work

We’re not a company that ships equipment and disappears. Continuous chromatography represents a meaningful shift in how purification works, and we’re committed to ensuring our clients succeed with it.

That commitment shows up in several ways: feasibility studies to assess whether our technology fits your specific challenge, advanced process modeling to optimize before you run, system rentals for evaluation, and hands-on workshops to build your team’s expertise. We offer preventive maintenance and repair services to keep your continuous chromatography systems in the best possible shape. Our ISO certification reflects the quality standards we maintain across system design, manufacturing, and ongoing support.

When you’re ready to scale, our partnership with YMC America ensures seamless transition from lab-scale development to GMP manufacturing. We view the relationship as a true partnership—your separation challenge becomes our problem to solve together.

Looking Forward

The biopharmaceutical landscape is shifting. Molecules are becoming more complex. Manufacturing demands are intensifying. Sustainability pressures are real.

We see continuous chromatography as central to meeting these challenges—not as a niche technique, but as the future standard for efficient, sustainable purification. The economics support it: 30–50% lower operating costs make continuous manufacturing increasingly compelling as the industry scales production of next-generation biologics and chemical medicines.

Our ongoing development work focuses on extending our technologies to emerging modalities while continuing to refine performance for established therapeutic classes. The goal hasn’t changed since 2006: enable more efficient, more sustainable production of medicines that improve lives. We’re just getting started.

The YMC Ecosystem: Systems, Media, and Global Support

Part of the YMC Group

Part of the YMC Group

YMC ChromaCon is the center of excellence for continuous chromatography within the YMC Group. Our sister companies bring decades of expertise in chromatography media, columns, and analytical systems — together we deliver end-to-end purification solutions from lab-scale development to full GMP manufacturing.

About the YMC Group
Explore Columns & Resins

Explore Columns & Resins

Looking for chromatography media, pre-packed columns, or bulk resins to run on your Contichrom® system? YMC Europe GmbH — our sister company — offers one of the broadest portfolios of chromatography media in the industry, with full technical support for method development and scale-up.

Visit YMC Europe
Global Reach, Local Support

Global Reach, Local Support

Customers worldwide rely on the Contichrom® platform. Through the YMC Group and our network of specialist distributors, you get localized expertise, fast service response, and direct access to our systems — wherever you operate.

Find a Distributor

Meet The Team

Experts in continuous chromatography, committed to your goals.

Dr. Thomas Müller-Späth
Dr. Thomas Müller-Späth CEO & Co-founder

Dr. Thomas Müller-Späth stands at the forefront of the shift from batch to continuous manufacturing in biopharma. As CEO of YMC ChromaCon, he combines deep chemical engineering expertise with a strategic vision to industrialize process intensification technologies.

Learn more
Dr. Lars Aumann
Dr. Lars Aumann CTO & Co-founder

The Architect of Intelligent Purification As Chief Scientific Officer, Dr. Lars Aumann leads the development of the software and process control strategies that power ChromaCon’s systems. He is responsible for translating complex chromatographic theory into the user-friendly, automated tools that allow the Contichrom® platform to outperform traditional batch systems.

Learn more
Dr. Sebastian Vogg
Dr. Sebastian Vogg Head of Research & Development

As Head of R&D at YMC ChromaCon, Dr. Sebastian Vogg leads the development of continuous chromatography solutions. His work focuses on process intensification and the integration of digital tools and automation into manufacturing workflows.

Learn more
Jennifer Kamer
Jennifer Kamer Head of Administration

Jennifer Kamer keeps YMC ChromaCon running with the same precision the company demands of its science. As Head of Administration, she is the operational backbone of the organization—overseeing finance, supply chain, order processing, and human resources with quiet efficiency and deep expertise.

A career built across industries:

Jennifer began her professional journey with a commercial apprenticeship, including a vocational baccalaureate, at a notary’s office in the canton of Zurich. This foundation shaped her expertise in financial and legal operations. She later led print and outdoor advertising at a major media agency before moving into senior leadership roles, including Head of Administration and Deputy CEO at Simba-Dickie (Switzerland) AG. She also managed the Swiss branch of Keyser & Mackay, gaining extensive experience in supply chain and business operations.

The engine behind the organization:

At YMC ChromaCon, Jennifer is responsible for accounting, accounts receivable and payable, financial reporting, purchasing, and end-to-end order management. She also oversees HR administration, including onboarding and offboarding processes. Her diverse cross-industry experience—from legal and media sectors to consumer goods and distribution—helps ensure YMC ChromaCon’s operational and commercial processes remain efficient, reliable, and forward-thinking.

Dr. Thomas Hug
Dr. Thomas Hug Head of Quality

As Head of Quality at YMC ChromaCon, Dr Thomas Hug serves as the guardian of our operational excellence. In an industry where purity and reproducibility are paramount, Thomas ensures that every Contichrom® system and consumable meets the rigorous standards required by our biopharmaceutical partners.

Learn more
Dr. Giulio Lievore
Dr. Giulio Lievore Key Account Manager

Dr. Giulio Lievore brings a unique “scientist-first” approach to his role as Account Manager for Europe. Unlike traditional sales representatives, Giulio holds a PhD in Chemical Sciences, where his research specifically focused on the transition from batch to continuous chromatography for therapeutic peptides.

Learn more

News & Event

2026 – Continuous Chromatography Workshop for mAbs, Oligonucleotides and Peptides
Events 08 Sep 2026

2026 – Continuous Chromatography Workshop for mAbs, Oligonucleotides and Peptides

From 8–10 September 2026, the Institute for Pharma Technology at FHNW hosts a 3-day seminar at the Muttenz (Basel) campus in Switzerland. Combining lectures, case studies and hands-on twin-column training, participants gain practical skills in continuous chromatography for mAbs, oligonucleotides, peptides and viral vectors.

See More News

YMC ChromaCon Chromatography Newsletter.
About one email a month. Unsubscribe anytime.

Trusted by Industry Leaders Worldwide

Proven Expertise

With decades of experience, YMC ChromaCon delivers chromatography systems trusted by scientists and manufacturers worldwide.

Certified Quality

Our products and processes comply with international standards, including GMP and ISO certifications, ensuring reliability and regulatory compliance.

Innovative Technologies

Proprietary continuous chromatography technologies that push the boundaries of purification efficiency and sustainability.

Global Impact

Used by leading biopharmaceutical companies to accelerate drug development and manufacturing.

Customer Success

Numerous validated case studies demonstrate consistent improvements in yield, purity, and cost-effectiveness.

Advance
Your Career in
Chromatography Innovation

View Open Roles Explore Our Technologies